Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sorry I'm "gloomy" at Mutual Admiration Society Meeting.
Smart investing is like smart writing. It's okay to break the rules as long as you understand the rules you are breaking, and as long as you break them with intention and purpose. Otherwise you just look ignorant and foolish.
My investment in ELTP breaks every rule. It's at the pinnacle of the risk pyramid. I have way too much money invested in a stock that costs less than a dollar and trades OTC, and I'm not properly diversified. I’ve done very well so far, but instead of taking profits, I keep buying more. If I ever showed my brokerage statements to a Registered Investment Advisor, I'd probably have to perform CPR on him. However, there is one rule I will not break: I do not have more at risk than I can afford to lose. Every year, we max out our 401K’s and Traditional IRA’s in “Retirement 2040” funds. But I don’t want to retire in 2040. I want to retire in 2021, and for that to happen, I need huge returns. Huge returns require huge risk- it requires breaking the rules- and I break them with intention and purpose. I accept huge risk, but I asses that risk constantly and understand it thoroughly.
I get the impression that some posters on this MB have no clue the kind of risk they’re involved in. If you rely on Investor Relations to answer your questions, you’re in trouble. Save your TRUST and FAITH for church. This is about MONEY, and I’m a scientist. I require FACTS and EVIDENCE. And when I don’t have them, I seek them. And when I’ve just proven I don’t have them, I don’t call others nonsensical.
kayak wrench, i'm already on the record...
...as both paranoid and cynical. And I'm already on the record as considering Epic to be the single greatest risk to my largest investment, my holdings of ELTP. My ELTP investment is worth more than my house, and I have a very nice house.
I'm not here to RA-RA-RA everything this company does, nor to bash it. You read every one of my posts and see that I shoot straight down the middle. I'm here to protect my investment by bringing to light any truth that I can.
It's fine by me if you are not concerned that the CEO has a secret relationship with the majority shareholders of a company in which you are a minority shareholder. I agree 100% with what N2KA just said. Secrecy causes you to question the reason for the secrecy. It undermines confidence. Make it public, so there are no questions about why it's a secret.
And here are my paranoid delusions about how Epic is the single greatest risk to my ELTP investment, which were in response to question about a potential Epic-ELTP merger:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=113217587
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=113220620
And remember, just because I'm paranoid does not mean they're not out to get me.
Pharma Sleuth, I thought of that possibility.
pte, Clarendon, kayak wrench, lasers... anybody can answer...
There is nothing in NOTE 25 of the latest 10K that describes why NH or Mikah is entitled to receive shares of ELTP *****FROM EPIC*****
Thanks for referring me to the 130 page 10-K and the link to the Elite Investor Relations SEC filings page. Very helpful. I am well-familiar with why NH received ELTP shares and warrants **from Elite**. But if anybody can point me to the public disclosure that explains why **EPIC** is compensating NH and Mikah with ELTP shares, I would greatly appreciate it.
pte, can you be a little more specific?
kayak wrench, this is the exact question...
no2koolaid, what is your opinion on disclosure?
Should there not be a public disclosure regarding how and why Epic is giving ELTP shares to NH, NH's IRA, and Mikah? Likewise with the Mikah labeling on hydroxyzine?
Clearly there exists a relationship between Epic, Nasrat Hakim, and Mikah. Why is this not publicly disclosed?
"Sunlight is said to be the best of disinfectants."
----Justice Louis Brandeis
Lasers, what about the Epic distribution to Mikah?
Under what authority or agreement is Mikah receiving shares of ELTP from Epic? Shouldn't those shares go into Elite treasury? Same question regarding Nasrat Hakim? Would it not be considered a material disclosure if Elite CEO has a separate and individual business arrangement with Elite's strategic partner Epic Pharma, outside of the relationship between Epic and Elite? Did I miss this disclosure?
Medicinal buccal cannabis troches.
http://www.trokie.com/product-info/
IB posted the label; I'm confused by it.
Hopefully we can get an explanation for this. May have something to do with site transfer technicalities. I already posted that I was surprised when Nasrat Hakim got share distributions from Epic, including under Mikah, which I thought was a defunct entity. Now the hydroxyzine label has Mikah's name on it?
Lasers? Anybody?
Huh. Not exactly "ceased operating" or "liquidating assets"
Epic's Hydroxyzine label:
http://epic-pharma.businesscatalyst.com/assets/hydroxyzine-hcl-tablets-usp-package-outsert.pdf
4/27/2015 4 Statement of Changes in Beneficial Ownership
http://b2i.api.edgar-online.com/EFX_dll/EdgarPro.dll?FetchFilingConvPDF1?SessionID=Zy-kefa7j5MBo-9&ID=10648486
2/17/2015 10-Q Quarterly Report
http://b2i.api.edgar-online.com/EFX_dll/EdgarPro.dll?FetchFilingConvPDF1?SessionID=Zy-kefa7j5MBo-9&ID=10492671
agrocraig11, ELTP and GNBT are both IP plays
They both hold extensive patents on legitimate technology with major market potential. I hope that GNBT will find its savior the way Jerry Treppel came to Elite, saved them from BK with Epic Pharma partnership, built a revenue base with generics, and now has handed the reins to Nasrat Hakim to develop their true money-makers, the abuse-deterrent opioids.
To have the insight that he was not the right guy to lead the company into the next phase of development and the judgement to bring in a guy like Nasrat Hakim to get the job done is extremely enviable. Remember when Elite was trading for a few pennies? Now at .22 and headed to multiple dollars soon. GNBT could do the same, but they need a Jerry Treppel and Nasrat Hakim. They have the technology but seem to be missing the leadership.
Nice to see you over here, keep on postin'! GLTY.
JJ, you're invited to a "Hairy Buffalo" party.
Depends on what your definition of "is" is.
Formulation and evaluation of simvastatin buccal film
Journal of Applied Pharmaceutical Science Vol. 5 (04), pp. 070-077, April, 2015
I'm interested. How will it be defeated?
Hi agrocraig11, the reverse split parameters are undefined.
Another spurt of buying with new "Intention" PR.
http://finance.yahoo.com/news/generex-announces-intention-dividend-portion-133000825.html
"Low Road" paved with cash, leads to NASDAQ.
gerhan, I think you're on the right track...
grobtekrebssvindl, there will be no news from India.
Awesome veeets! Great DD. Thanks.
This is what I've been looking for:
Saturday, May 30 | 8:00 AM - 11:30 AM
Breast Cancer—HER2/ER
Session Type: Poster Session
Track(s): Breast Cancer
Presentation(s):
Abstract #622
Final pre-specified analysis of the phase II trial of the AE37+GM-CSF vaccine in high risk breast cancer patients to prevent recurrence.
Julia M. Greene, MD
San Antonio Military Medical Center
Welcome gerhan. You must be new to GNBT.
I appreciate your posts, but the management of this company, current and previous, have a bit of a habit of making statements that don't pan out. I've listened to Mark Fletcher's interview on Wall Street Analyzer- tyically tantalizing, low on specifics.
Again, one can go to the ASCO site and look for one's self. There are no current listings for any presentations that involve AE37. No oral presentations, no posters. If I'm wrong please link to the presentation or provide the title or presenter. I want to be wrong! I want AE37 at ASCO! But this meeting is coming up this month. All the sessions are already set- have been for months. The company released the ASCO PR in February. Where is AE37 at ASCO?
https://iplanner.asco.org/am2015/AM2015.aspx
Hi gerhan, can you provide a link?
Bill to Speed Approvals for Drugs Cut Back
By SABRINA TAVERNISE
APRIL 30, 2015
http://www.nytimes.com/2015/05/01/health/bill-to-speed-approvals-for-drugs-is-cut-back.html?_r=0
I bet ELTP is a trader's dream stock.
grobtekrebssvindl, thanks for the link
I had not seen that interview. I think it would go a really long way if Generex would bring in some fresh blood. Somebody with both Scientific chops and Management chops, of which M. Fletcher has neither. Bringing in someone with positive experience running a developmental-stage biotech would maybe assuage some of the restless, disgruntled longs and also attract some newbie investors.
The question is if anybody good would even take the job!
GLTY
Alternate Routes of Administration of Antidepressant and Antipsychotic Medications
Ann Pharmacother April 23, 2015
http://www.empr.com/alternate-administration-routes-for-psychotropic-drugs-reviewed/article/411332/
There are no missing rungs on the ladder.
Every step necessary to organically grow and increase the value of this company is already there. There are no gaps that need to be filled by a partner, merger, or reverse split. Just take 1 step at a time. Some will complain about how long each step is taking. Others will complain that the price per share does not increase enough with each step. But no matter the time frame or the price, the value increases with each step, and there are no missing rungs on the ladder.
Eventually, price and value always find equilibrium, and those who are holding shares at that point will be very happy.
Elite has the ability to go it alone.
They have the expertise to develop, get approval for, and manufacture any number of ADF Opioids. But I think they'll have to call in some help in order to most-effectively market and sell them. But contracting for a sales force requires much less of a commitment than taking on a partner.
It's kind of like the difference between hiring somebody to mow your lawn vs. marrying somebody to help pay the mortgage. You don't have to put out for the lawnboy...
'grobtekrebssvindl' what attribute of GNBT caused you to invest?
I'm assuming you have invested and are underwater, just based on the tone of your posts. But that means at some point you looked at the company and saw something(s) you liked. I get that you are profoundly disappointed in management, and I share your frustration.
You don't have to say when or how much or anything like that, but what made you pull the trigger when you bought your first shares?
GLTY
Chuc, I'm sure it would be evidence in a class-action lawsuit.
N2K, I HATE the idea of merger with Epic.
Such a merger would provide the easiest means of screwing ELTP shareholders. Your posts this week on valuation have been very enlightening, and they cause me to recall this:
http://ir.elitepharma.com/profiles/investor/ResLibraryView.asp?ResLibraryID=74676&GoTopage=2&Category=2163&BzID=2258&t=1948&G=939
A working man sold $20,000 worth of stock.
Form 4 today. John P. Barratt converted warrants.
http://archive.fast-edgar.com//20150427/ATZZO22C2222C2U222232CZ2BAR5Z2278C72/
5,874,162 shares at a strike price .001. (That is $5874.16!) This follows the 8-K filing last month announcing his resignation from BOD "for medical reasons," effective April 30, 2015.
http://archive.fast-edgar.com//20150407/A6ZFW22C2222H2S2222M2CZ29A5LZ2278272/
Assuming the Restrictive Legend is immediately removed (http://www.sec.gov/answers/restric.htm), and assuming GNBT remains a "going concern" in 6 months (or 1 year), and assuming the PPS remains in range of .02, then these shares can be sold on open market for $117,483.24 (not a bad return for $5874 investment). Of course, we'll never know when he sells, since he's no longer on BOD with duty to report.
And these shares are just a drop in the bucket for Mr. Barratt:
http://www.sec.gov/cgi-bin/browse-edgar?CIK=0001270529&action=getcompany
So good health to Mr. Barrat, and good luck to all longs!
There was no dilution yesterday re: Form 4's
cicle1, I think it is what it is
Breakdown of yesterday's Form 4's:
13,760,695 (NH)
2,700,000 (")
2,570,018 (")
12,850,089 (NJ)
19,275,133 (AN)
--------------
51,155,935 (Insider Total)
67,659,232 - 51,155,935 = 16,503,297 - 51,155,935 = 16,503,297 (Non-insider total)
Total shares remaining under Epic Investments = Zero
Of the 67,659,232 shares distributed, insiders with reporting obligations received 51,155,935 shares. These shares are not restricted and they may sell those shares at any time but not without SEC filing. The remaining 16,503,297 shares went to non-insiders who may sell those shares at any time without notification. (I suspect Ram Potti receives most if not all of those shares). These shares are all previously accounted for and do not represent dilution or conversion of warrants. No shares were bought or sold. Epic Investments has no remaining shares.
If I am reading these incorrectly, somebody with more expertise in this area please correct.